Madrigal Pharmaceuticals (MDGL) Insider Trading & Ownership $308.44 +15.03 (+5.12%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Madrigal Pharmaceuticals (NASDAQ:MDGL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$42.87 M Get MDGL Insider Trade Alerts Want to know when executives and insiders are buying or selling Madrigal Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MDGL Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Madrigal Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/3/2024Fred B CravesDirectorSell3,600$315.31$1,135,116.00 11/25/2024Fred B CravesDirectorSell3,400$350.30$1,191,020.00 11/1/2024Richard S LevyDirectorSell5,000$300.94$1,504,700.00 9/9/2024William John SiboldCEOSell6,363$243.83$1,551,490.29 6/14/2024Robert E WaltermireVPSell1,900$280.00$532,000.00 6/12/2024Robert E WaltermireVPSell2,000$285.00$570,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/21/2024Robert E WaltermireVPSell1,036$231.34$239,668.24 5/14/2024Fred B CravesDirectorSell22,489$212.88$4,787,458.32 4/8/2024Paul A FriedmanDirectorSell26,270$246.19$6,467,411.30 4/8/2024Rebecca TaubCMOSell2,676$245.99$658,269.24 4/5/2024Rebecca TaubCMOSell27,506$243.36$6,693,860.16 4/4/2024Paul A FriedmanDirectorSell18,710$242.96$4,545,781.60 4/3/2024Rebecca TaubCMOSell27,845$245.14$6,825,923.30 4/1/2024James M DalyDirectorSell32,489$102.77$3,338,894.53 4/1/2024Richard S LevyDirectorSell11,000$257.48$2,832,280.00 (Data available from 1/1/2013 forward) MDGL Insider Trading Activity - Frequently Asked Questions Who is on Madrigal Pharmaceuticals's Insider Roster? The list of insiders at Madrigal Pharmaceuticals includes Brian Joseph Lynch, Bros. Advisors Lp Baker, Fred B Craves, James M Daly, Paul A Friedman, Rebecca Taub, Remy Sukhija, Richard S Levy, Robert E Waltermire, and William John Sibold. Learn more on insiders at MDGL. What percentage of Madrigal Pharmaceuticals stock is owned by insiders? 22.80% of Madrigal Pharmaceuticals stock is owned by insiders. Learn more on MDGL's insider holdings. Which Madrigal Pharmaceuticals insiders have been buying company stock? The following insider purchased MDGL shares in the last 24 months: Bros. Advisors Lp Baker ($43,382,043.47). How much insider buying is happening at Madrigal Pharmaceuticals? Insiders have purchased a total of 226,067 MDGL shares in the last 24 months for a total of $43,382,043.47 bought. Which Madrigal Pharmaceuticals insiders have been selling company stock? The following insiders have sold MDGL shares in the last 24 months: Brian Joseph Lynch ($6,787,946.00), Fred B Craves ($7,113,594.32), James M Daly ($3,338,894.53), Paul A Friedman ($11,013,192.90), Rebecca Taub ($14,178,052.70), Remy Sukhija ($8,224,200.00), Richard S Levy ($10,929,630.35), Robert E Waltermire ($1,905,168.24), and William John Sibold ($1,551,490.29). How much insider selling is happening at Madrigal Pharmaceuticals? Insiders have sold a total of 273,073 Madrigal Pharmaceuticals shares in the last 24 months for a total of $65,042,169.33 sold. Madrigal Pharmaceuticals Key ExecutivesDr. Rebecca A. Taub M.D. (Age 72)Founder, Chief Medical Officer, President of Research & Development and Director Compensation: $939.83kMr. Brian J. Lynch J.D. (Age 62)Senior VP & General Counsel Compensation: $763.75kMr. Alex G. Howarth (Age 55)Executive Officer Compensation: $757.26kMr. William J. Sibold (Age 58)CEO, President & Director 1 recent tradesMs. Mardi C. Dier (Age 60)CFO, Principal Financial Officer, Principal Accounting Officer & Senior VP Mr. Ronald FilippoChief Information OfficerMs. Tina E. VenturaChief Investor Relations OfficerDr. Kianoush Motesharei Ph.d. (Age 54)Senior Vice President of Business & Corporate Development Mr. Clint WallaceChief Human Resources OfficerMr. Edward ChiangSenior Vice President of Clinical & Technical Operations More Insider Trading Tools from MarketBeat Related Companies Biogen Insider Buying United Therapeutics Insider Buying Neurocrine Biosciences Insider Buying Incyte Insider Buying BioMarin Pharmaceutical Insider Buying Exact Sciences Insider Buying Exelixis Insider Buying Repligen Insider Buying Halozyme Therapeutics Insider Buying Ionis Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:MDGL) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDGL Stock Alerts